Persistent expression of canine factor IX in hemophilia B canines (Q45862802)

17 December 2017

title

Persistent expression of canine factor IX in hemophilia B canines (English)

1 reference

17 December 2017

main subject

hemophilia

0 references

coagulation factor IX

0 references

hemophilia B

0 references

author name string

Chao H

1

1 reference

17 December 2017

Samulski R

2

1 reference

17 December 2017

Bellinger D

3

1 reference

17 December 2017

Monahan P

4

1 reference

17 December 2017

Nichols T

5

1 reference

17 December 2017

Walsh C

6

1 reference

17 December 2017

publication date

1 October 1999

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

6

1 reference

17 December 2017

issue

10

1 reference

17 December 2017

page(s)

1695-1704

1 reference

17 December 2017

Hepatitis A virus infections associated with clotting factor concentrate in the United States

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Haemophilia prophylaxis in young patients--a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Adeno-associated virus expression systems for gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Quantitative analysis of the packaging capacity of recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Expression of human factor IX in mice after injection of genetically modified myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Canine hemophilia B resulting from a point mutation with unusual consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Role of intron I in expression of the human factor IX gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Viral receptors and vector purification: new approaches for generating clinical-grade reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Recombinant adeno-associated virus for muscle directed gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

Selective extraction of polyoma DNA from infected mouse cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

In vivo model of adeno-associated virus vector persistence and rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

7 January 2021

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

7 January 2021

Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

7 January 2021

Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

7 January 2021

Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

7 January 2021

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

7 January 2021

Human factor IX binds to specific sites on the collagenous domain of collagen IV

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301024

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301024

1 reference

17 December 2017

Dimensions Publication ID

1008888203

0 references

Fatcat ID

release_zyo3qk4bdba5fk2fvlolsmx6aq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zyo3qk4bdba5fk2fvlolsmx6aq

24 November 2022

mapped directly with Wikidata item

1 reference

17 December 2017